Hiten Patel

724 posts

Hiten Patel banner
Hiten Patel

Hiten Patel

@HitenDPatel

Urologic Oncologist @NM_Urology & @ChicagoVAMC @WUSTL, @HopkinsMedicine, @JohnsHopkinsSPH, @brady_urology, @LoyolaUrology @UroOnc Views are my own. #BLM

Chicago, IL Katılım Temmuz 2012
705 Takip Edilen1.1K Takipçiler
Hiten Patel
Hiten Patel@HitenDPatel·
@LauraBukavinaMD Lol why were they allowed to conjecture about complex cases being first as a caveat rather than the main finding. Need data on last case outcomes stratied by surgeons needing to get to a kids sports game or not.
English
0
0
1
96
Laura Bukavina
Laura Bukavina@LauraBukavinaMD·
everyone knows you do your toughest case first .. even when you adjust for "complexity" the surgeon knows what case goes first so results are not surprising .. it is not the timing of the day it is the surgeons Choice of who goes first and for what reasons
Annals of Surgery@AnnalsofSurgery

In this multicenter observational study, first elective operations of the day were associated with higher rates of adverse postoperative events than operations performed later in the day. journals.lww.com/annalsofsurger…

English
7
3
54
14.1K
Hiten Patel retweetledi
Matt Cooperberg
Matt Cooperberg@dr_coops·
And just like that, an era ended. Neoadj chemo before cystectomy is now a historical footnote #ev304 #keynoteb15 #ASCO26
QianJanieQin@QianJanieQin

PRACTICE CHANGING: #KEYNOTEB15/EV304- in #MIBC, periop EV/P led to sig EFS (NR v 48.5m, 24m EFS 79.4 v 66.2%, HR0.53; 0.41-0.7), OS (NR v NR, 24m estimated OS 86.9 v 81.3%, HR 0.65; 0.48-0.89), pCR  (55.8 v 32.5%) benefit v. neoadj gem/cis, supporting EV/P as SOC in this setting

English
4
7
35
10.4K
Hiten Patel retweetledi
NEJM
NEJM@NEJM·
New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: nej.md/DrG40
English
9
98
424
103.9K
Hiten Patel retweetledi
NM Urology
NM Urology@NM_Urology·
#AUA26 is just 4 days away! @NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world. Meet our representatives and follow along for conference updates!
NM Urology tweet media
English
0
4
11
1.7K
Hiten Patel retweetledi
NM Urology
NM Urology@NM_Urology·
🚨 PUBLICATION ALERT 🚨 Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications Authors included: Ashley Ross, MD, PhD, Edward Schaeffer, MD, PhD (@EdwardSchaeffer), Hiten Patel, MD (@HitenDPatel), Jamie Michael, MD, Nicole Handa, MD Publication link: nature.com/articles/s4169…
NM Urology tweet media
English
0
2
4
647
Brad Gill
Brad Gill@BradGillMD·
Privileged to have friend & colleague @kvnkoo from @MayoUrology join @OhioUroSociety tonight as political / advocacy keynote speaker. Huge motivation & essential insights from him as chair of @AmerUrological Federal Advocacy Committee, and his many many other roles!
Brad Gill tweet mediaBrad Gill tweet media
English
1
4
19
1.3K
Hiten Patel
Hiten Patel@HitenDPatel·
@CanesDavid @DrSpratticus @uroegg @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy Adjusting for PIRADS, DRE ended up with the opposite association with csPCa (PMID 35733400, Table 2) than negative or unknown status in PLUM. Excluded from final model. bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj… Some benefit to DRE in other studies. pubmed.ncbi.nlm.nih.gov/35475129/
English
0
0
0
65
Hiten Patel
Hiten Patel@HitenDPatel·
Purple = prostate peripheral zone, Green = prostate transition zone, White = seminal vehicles, Brown = PANIC, Yellow = bladder, Orange = Tumor and cytokines
English
0
0
2
157
Hiten Patel retweetledi
Yahoo Sports
Yahoo Sports@YahooSports·
ARE WE WITNESSING THE BEST INDIVIDUAL PERFORMANCE EVER IN THE POSTSEASON ⁉️ 🧊 3 HR 🧊 6 scoreless IP 🧊 10 Ks SHOHEI OHTANI IS REALLY HIM 🐐
Yahoo Sports tweet media
English
61
549
4.6K
132.7K
Hiten Patel retweetledi
NM Urology
NM Urology@NM_Urology·
The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter
English
1
13
46
3.1K
Hiten Patel retweetledi
Urologic Oncology
Urologic Oncology@UrolOncol·
📰New in @UrolOncol! 💡Highlights: 1⃣Presence of EPE on MRI predicted prostatectomy outcomes 2⃣Combined biopsy showed the highest rate of grade concordance with prostatectomy 3⃣Our model for adverse surgical pat did not outperform existing nomograms 🔗bit.ly/4kGCuoS
Urologic Oncology tweet media
English
1
5
18
1.4K
Hiten Patel retweetledi
NEJM
NEJM@NEJM·
Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO
NEJM tweet media
English
18
355
812
219.8K